Navigation Links
New England Peptide, Inc. and Cambridge Isotope Laboratories, Inc. Announce Quantitative Proteomics Manufacturing Collaboration
Date:7/16/2013

Gardner, MA (PRWEB) July 16, 2013

New England Peptide, Inc. (NEP) and Cambridge Isotope Laboratories, Inc. (CIL) announced a joint manufacturing and marketing agreement of pre-loaded resins for the synthesis of peptide stable isotope standards (SIS).

Under the terms of the agreement CIL will provide high purity stable isotope amino acids to NEP and NEP will load the isotopologues onto peptide synthesis resins, perform quality control on the resins, and redistribute to CIL. Both companies have agreed to co-market and sell the pre-loaded resins to peptide synthesis laboratories worldwide.

"We saw this collaboration as an important way to facilitate the synthesis of peptide stable isotope standards (SIS). This product will increase the availability and decrease the cost of SIS peptides, which will help the quantitative proteomics field grow", commented Sam Massoni, President and CEO of New England Peptide, Inc.

The gold standard for MS-based quantitative methods is to use a mass-shifted, stable-isotope-labeled peptide standard spiked into the sample of interest, which then allows quantification from a simple ratio of the labeled peak height to the unlabeled. This collaboration is further evidence of NEP and CIL’s commitment to the field.

"We were the first company to manufacture protected stable isotope labeled amino acids at 99% isotopic enrichment. NEP was one of the reasons we have been expanding our production of these 99% enriched reagents. NEP requested the highest quality reagents to meet the increased demand of SIS peptides, and we met that need. This collaboration is a natural fit for both companies and adds value to both product lines", commented Maureen Duffy, VP of Sales and Marketing at Cambridge Isotope Laboratories, Inc.

NEP is one of the premier peptide synthesis companies.

About New England Peptide (NEP)

New England Peptide, founded in 1998, designs and manufactures peptides and polyclonal antibodies for drug and vaccine discovery organizations worldwide. Headquartered in the Boston metro area in Gardner, MA., the company’s chemists and immunological experts specialize in delivering a full range of services for biotech and pharmaceutical applications. NEP is a worldwide leader in providing SIS peptides for the quantitative proteomics field. More information on NEP can be found at http://www.newenglandpeptide.com.

About Cambridge Isotope Laboratories, Inc. (CIL)

CIL is the world’s leading manufacturer of stable isotope labeled reagents for research applications in proteomics, genomics, molecular biology, metabolic research, clinical and diagnostic research and ultra trace environmental analysis. For over 30 years CIL has provided over 15,000 different research compounds to its base of over 35,000 medical, pharmaceutical, academic and government customers.

CIL corporate headquarters are located in Tewksbury, MA. More information on CIL can be found at http://www.isotope.com.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10920006.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Rates of infection in intensive care units in England show impressive fall
2. University of New England and Partners Celebrate Opening of Portland Community Health Center at Riverton June 20 for Underserved Populations
3. National HealthCare Associates Acquires Five New Centers throughout New England
4. University of New England Graduates First Class with Pharmacy Doctoral Degrees
5. Luke Cooper, CEO, Asurvest, Inc., Nominated For The New England Patriots Myra Kraft Community MVP Award
6. Moderate Red Tide Expected in New England This Summer
7. Hospital remains most common place of death for cancer patients in England
8. Cosmetic Enhancement Center of New England Now Has Satellite Locations
9. New Englanders Without IVF Coverage Have a More Affordable Way to Seek Help Through the WINFertility® Treatment Program
10. Just a drop? Alcohol consumption much higher than reported in England
11. Care New England Executive selected for prestigious program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... Minneapolis, Minnesota (PRWEB) , ... July 19, 2017 ... ... in healthcare experience, recently hiring senior healthcare project manager, Josh Christensen. As a ... the nation and looks to further its healthcare resume in the Midwest with ...
(Date:7/20/2017)... ... July 20, 2017 , ... “Lucky the Buffalo and Her Adventures”: a collection of heartwarming children’s ... Bieniek. Edward Steven Bieniek Jr. was born in Toledo, Ohio. He attended Woodward ... tech. He is married to a brilliant woman with a caring heart named Tiina, ...
(Date:7/18/2017)... ... ... an international clinical trial, led in part by a UC Davis School of Medicine expert, ... for a subgroup of patients. , In a paper just published online in the journal ... 18 countries describe the clinical benefit of using the drug ataluren for a certain group ...
(Date:7/18/2017)... ... , ... Heritage Woods of Benton, a Gardant affordable assisted living community is ... , The community, which is located at 1305 Bailey Lane in Benton, Illinois, serves ... maintain their independence. , The lunch menu will include Hawaiian chicken, meatballs and coleslaw. ...
(Date:7/17/2017)... ... July 18, 2017 , ... ... PICOPLUS 450 ps pulse width and a new published paper entitled ‘Pattern ... in tissue-mimicking phantom’ featured in Nature’s specialty journal Scientific Reports May 08, ...
Breaking Medicine News(10 mins):
(Date:6/30/2017)... June 30, 2017  AVACEN Medical (AVACEN) announced the publication of ... describes the use of its AVACEN Treatment Method to ... fibromyalgia. ... AVACEN Medical ... chronic widespread pain. It affects approximately 200 to 400 million people worldwide ...
(Date:6/27/2017)...  Therapix Biosciences Ltd. (Nasdaq: TRPX ) ... development of cannabinoid-based drugs, today announced that the Company ... New York, NY on Wednesday, ... offering (IPO) of American Depository Shares (ADSs) listed on ... Dr. Elran Haber, Ph.D., Chief Executive Officer of Therapix, ...
(Date:6/20/2017)... Netherlands and LAGUNA HILLS, Calif. ... the presentation of new data that validate the use ... risk stratify patients with multiple myeloma (MM). In a ... the European Hematology Association (EHA) in Madrid, ... value of MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology: